REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $144 | -54.7% | 12,583 | 0.0% | 0.00% | -66.7% |
Q2 2023 | $318 | -13.6% | 12,583 | +10.3% | 0.00% | 0.0% |
Q1 2023 | $368 | +49.6% | 11,412 | -14.5% | 0.00% | +50.0% |
Q4 2022 | $246 | -99.9% | 13,346 | +15.0% | 0.00% | -33.3% |
Q3 2022 | $313,000 | +104.6% | 11,607 | +5.0% | 0.00% | +200.0% |
Q2 2022 | $153,000 | -31.4% | 11,052 | -3.3% | 0.00% | -50.0% |
Q1 2022 | $223,000 | -44.8% | 11,428 | -53.7% | 0.00% | +100.0% |
Q4 2021 | $404,000 | +15.8% | 24,708 | +97.1% | 0.00% | -66.7% |
Q3 2021 | $349,000 | -11.2% | 12,536 | -5.4% | 0.00% | 0.0% |
Q2 2021 | $393,000 | +73.1% | 13,255 | +63.2% | 0.00% | -66.7% |
Q1 2021 | $227,000 | -9.2% | 8,120 | -7.9% | 0.01% | 0.0% |
Q4 2020 | $250,000 | +13.1% | 8,815 | +0.4% | 0.01% | -10.0% |
Q3 2020 | $221,000 | – | 8,776 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |